Literature DB >> 3320348

Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.

M Picker1, L A Dykstra.   

Abstract

Pigeons were trained to discriminate a dose of either 4.2 mg/kg of U50,488 or 1.0 mg/kg of morphine from water using a two-key drug discrimination procedure. In U50,488-trained pigeons, the kappa agonist bremazocine occasioned drug-appropriate responding during substitution tests, whereas ethylketocyclazocine and ketocyclazocine occasioned intermediate levels of drug-appropriate responding up to and including doses that markedly suppressed response rates. The mu agonists morphine, l-methadone and fentanyl produced responding predominantly on the water-appropriate key. In morphine-trained pigeons, l-methadone, fentanyl, ethylketocyclazocine and ketocyclazocine, but not U50,488 and bremazocine, occasioned drug-appropriate responding. Nonopioid compounds, such as d-amphetamine, pentobarbital, phencyclidine and (+)-SKF 10,047 produced responding predominantly on the water-appropriate key in both U50,488- and morphine-trained pigeons. During tests of antagonism, a 0.1 and 1.0 mg/kg dose of naloxone antagonized completely the discriminative stimulus properties of the training dose of U50,488 and morphine, respectively. In addition, morphine displayed a substantially longer duration of action than U50,488, in that intermediate levels of drug-appropriate responding were evident as long as 4 hr after the administration of morphine and only 1 hr after the administration of U50,488. Over a period of approximately 8 months, the dose-effect curves for the discriminative stimulus properties of both drugs were unchanged. The present findings illustrate further the unique behavioral response of pigeons to the discriminative stimulus properties of the kappa agonists, and establishes that pigeons can discriminate between mu and some kappa agonists.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3320348

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.

Authors:  K W Locke; B Gorney; M Cornfeldt; S Fielding
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Drug discrimination in pigeons trained to discriminate among morphine, U50488, a combination of these drugs, and saline.

Authors:  William D Wessinger; Mi Li; Donald E McMillan
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Drug Discrimination and the Analysis of Private Events.

Authors:  Brian D Kangas; David R Maguire
Journal:  Behav Anal (Wash D C)       Date:  2016-03-14

4.  Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.

Authors:  S G Holtzman; L Cook; G F Steinfels
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.

Authors:  D C Jewett; H I Mosberg; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

6.  Serotonin involvement in the discriminative stimulus effects of kappa opioids in pigeons.

Authors:  M E Bronson; Y P Lin; K Burchett; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.

Authors:  M Ohno; T Yamamoto; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons.

Authors:  A J Mattox; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.